Insight Capital Research & Management »

Emergent BioSolutions shares owned by Insight Capital Research & Management

Quarter-by-quarter ownership of Emergent BioSolutions (EBS) shares owned by Insight Capital Research & Management from 13F filings

Historical chart of Insight Capital Research & Management investment in Emergent BioSolutions

Tip: Access up to 7 years of quarterly data

All positions including Emergent BioSolutions held by Insight Capital Research & Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Emergent BioSolutions by Insight Capital Research & Management

Quarter filed Position value Share count Share price at filing
2017-09-30 $1.3M 31k 40.46
2016-03-31 $7.4M 203k 36.35
2015-12-31 $8.3M 208k 40.01
2015-09-30 $5.9M 207k 28.49

More positions owned by Insight Capital Research & Management

Apple (AAPL)
Facebook Inc cl a (META)
Microsoft Corporation (MSFT)
Brink's Company (BCO)
Raytheon Company
Amazon (AMZN)
Align Technology (ALGN)
Servicenow (NOW)
Msci (MSCI)
Square Inc cl a (SQ)
Activision Blizzard
Rogers Corporation (ROG)
Blucora
Sherwin-Williams Company (SHW)
Boeing Company (BA)

View all positions for Insight Capital Research & Management

Top funds holding Emergent BioSolutions

Vanguard Group
Charles Schwab Investment Management
Millennium Management
Hotchkis and Wiley Capital Management
D. E. Shaw & Co
Two Sigma Advisers
Jacobs Levy Equity Management
Two Sigma Investments
Prescott Group Capital Management
Assenagon Asset Management
Goldman Sachs Group
Dimensional Fund Advisors
AQR Capital Management
Cubist Systematic Strategies
Values First Advisors

View all funds holding Emergent BioSolutions